Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaisson

Showing results (101-110 of 744) with videos related to

Pageof 75
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virusM J Glesby, R D Moore, R E Chaisson
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV antigen variability in ARC/AIDSC W Hendrix, P A Volberding, R E Chaisson
The Journal of Infectious Diseases|November 1, 1993
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study GroupM J Glesby, R D Moore, R E Chaisson
Alcoholism, Clinical and Experimental Research|February 1, 1991
Plasma protein catabolism in ethanol- and colchicine-treated liver slicesT M Donohue, M L Chaisson, R K Zetterman
Pediatrics|November 5, 2003
Keeping children out of hospitals: parents' and physicians' perspectives on how pediatric hospitalizations for ambulatory care-sensitive conditions can be avoidedGlenn Flores, Milagros Abreu, Christine E Chaisson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
AIDS (London, England)|November 8, 2001
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapyT R Sterling, R E Chaisson, R D Moore
AIDS (London, England)|September 8, 2001
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenzG M Lucas, R E Chaisson, R D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Differences in HIV disease progression by injecting drug use in HIV-infected persons in careRichard D Moore, Jeanne C Keruly, Richard E Chaisson
Chest|November 21, 1998
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complicationsJ E Gallant, R E Chaisson, R D Moore
Pageof 75

Showing results (101-110 of 744) with videos related to

Sort By:
Pageof 75
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virusM J Glesby, R D Moore, R E Chaisson
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV antigen variability in ARC/AIDSC W Hendrix, P A Volberding, R E Chaisson
The Journal of Infectious Diseases|November 1, 1993
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study GroupM J Glesby, R D Moore, R E Chaisson
Alcoholism, Clinical and Experimental Research|February 1, 1991
Plasma protein catabolism in ethanol- and colchicine-treated liver slicesT M Donohue, M L Chaisson, R K Zetterman
Pediatrics|November 5, 2003
Keeping children out of hospitals: parents' and physicians' perspectives on how pediatric hospitalizations for ambulatory care-sensitive conditions can be avoidedGlenn Flores, Milagros Abreu, Christine E Chaisson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
AIDS (London, England)|November 8, 2001
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapyT R Sterling, R E Chaisson, R D Moore
AIDS (London, England)|September 8, 2001
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenzG M Lucas, R E Chaisson, R D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Differences in HIV disease progression by injecting drug use in HIV-infected persons in careRichard D Moore, Jeanne C Keruly, Richard E Chaisson
Chest|November 21, 1998
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complicationsJ E Gallant, R E Chaisson, R D Moore
Pageof 75